Alastair Garfield
Direttore Tecnico/Scientifico/R&S presso RHYTHM PHARMACEUTICALS, INC.
Profilo
Dr. Alastair Garfield is a Chief Scientific Officer at Rhythm Pharmaceuticals, Inc. Dr. Garfield was previously employed as a Head-Lab by Pfizer Inc., a Senior VP & Head-Translational Research by Rectify Pharmaceuticals LLC, and an Assistant Professor by The University of Edinburgh.
He received his graduate degree from the University of Bath and a doctorate degree from the University of Bath.
Posizioni attive di Alastair Garfield
| Società | Posizione | Inizio |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2024 |
Precedenti posizioni note di Alastair Garfield
| Società | Posizione | Fine |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2021 |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Corporate Officer/Principal | - |
| The University of Edinburgh | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Formazione di Alastair Garfield
| University of Bath | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Commercial Services |
- Borsa valori
- Insiders
- Alastair Garfield
